期刊文献+

阿托伐他汀对冠状动脉慢血流的作用 被引量:4

Effect of atorvastatin on patients with coronary slow flow
原文传递
导出
摘要 目的:研究阿托伐他汀在冠状动脉慢血流患者中的治疗作用。方法:将72例冠状动脉慢血流患者随机分为阿托伐他汀组(38例)和对照组(34例)。对照组采用拜阿司匹林100mg/d、单硝酸异山梨酯20mg/d、曲美他嗪20mg/d联合治疗,阿托伐他汀组在此基础上加用阿托伐他汀20mg/d治疗。观察治疗前后两组患者冠状动脉TIMI血流分级和冠状动脉血流储备的变化。结果:阿托伐他汀组冠状动脉TIMI血流改善的有效率较对照组明显增高(P<0.05),冠状动脉血流储备值较治疗前明显增高(P<0.05)。对照组冠状动脉血流储备值较治疗前无显著性变化(P>0.05)。结论:长期阿托伐他汀治疗可改善冠状动脉慢血流患者TIMI血流分级和冠状动脉血流储备功能。 Objective:To study the therapeutic effect of atorvastatin on patients with coronary slow flow. Meth- od:The 72 cases with coronary slow flow were randomly divided into the atorvastatin treatment group (n = 38) and control group (n=34). The control group was treated with aspirin (100 mg/d), isosorbide mononitrate (20 mg/ d) and trimetazidine(20 mg/d). The atorvastatin treatment group was treated with atorvastatin on the basis of the routine treatment. The changes of TIMI grade of coronary artery blood flow and coronary flow reserve between two groups were observed before and after treatment. Result:The effective rate on the improvement of TIMI grade of coronary artery blood flow in the treatment group was significantly higher than the control group (P〈0.05), and the coronary flow reserve values were significantly increased compared with those before treatment (P〈0.05). The coronary flow reserve values of control group had no significant changes than before treatment (P〉0.05). Conclusion:The long term atorvastatin therapy may improve the TIMI grade of coronary artery blood flow and coronary flow reserve in the patients with coronary slow flow.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2013年第7期510-512,共3页 Journal of Clinical Cardiology
基金 武汉市卫生局科研项目(No:WX12D06)
关键词 冠心病 阿托伐他汀 冠状动脉造影 冠状动脉血流储备 慢血流 coronary disease atorvastatin coronary angiography coronary flow reserve coronary slow flowphenomenon
  • 相关文献

参考文献6

  • 1DE BROYNE B, HERSBACH F, PULS N H, et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "normal" coronary angiography [J]. Circulation, 2001 , 104: 2401- 2406. 被引量:1
  • 2BELTRAME J F, LIMAYE S B, HOROWITZ J D. The coronary slow flow phenomenon-a new coronary microvascular disorder[J]. Cardiology, 2002,97: 197 - 202. 被引量:1
  • 3TAMBE A A, DEMANY M A, ZIMMERMAN H A, et al. Angina pectoris and slow flow velocity of dye in coronary arteries a new angiographic finding [J]. Am Heart J,1972,84:66-71. 被引量:1
  • 4NOTO N, KARASAWA K, AYUSAW M, et al. Measurement of coronary flow reserve in children by transthoracic Doppler echo cardiography [J]. Am J Cardiol , 1997 ,80: 1638-1639. 被引量:1
  • 5MANGIERI E, MACCHIARELLI G, CIAVOLELLA M, et al. Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries[J]. Cathet Cardiovasc Diagn , 1996,37: 375 - 381. 被引量:1
  • 6樊瑛,杨树森,于江波,都金红,韩薇,甘润韬,王政,李为民,黄永麟.阿托伐他汀对冠状动脉血流缓慢患者冠状动脉血流储备的影响[J].中华心血管病杂志,2010,38(2):143-146. 被引量:23

二级参考文献14

  • 1De Bruyne B, Hersbach F, Pijls NH, et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "normal" coronary angiography. Circulation, 2001, 104 : 2401- 2406. 被引量:1
  • 2Beltrame ,IF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon- a new coronary microvascular disorder. Cardiology, 2002, 97: 197-202. 被引量:1
  • 3Dimitrow PP. Transthoracic Doppler echocardiography-noninvasive diagnostic window for coronary flow reserve assessment. Cardiovasc Ultrasound, 2003, 1:4. 被引量:1
  • 4Erdogan D, Gullu H, Caliskan M, et al. Coronary flow reserve is preserved in white-coat hypertension. Heart, 2006, 92 : 1109- 1112. 被引量:1
  • 5Erdogan D, Caliskan M, Gullu H, et al. Coronary flow reserve is impaired in patients with slow coronary flow. Atherosclerosis, 2007, 191 : 168-174. 被引量:1
  • 6Beltrame JF, Limaye SB, Wuttle RD, et al. Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. Am Heart J, 2003, 146: 84-90. 被引量:1
  • 7Camsari A, Ozcan T, Ozer C, et al. Carotid artery intima-media thichness correlates with intravascular ultrasound parameters in patients with slow coronary flow. Atherosclerosis, 2008, 200: 310-314. 被引量:1
  • 8Sezgin AT, Sigirci A, Barutcu I, et al. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis, 2003, 14 : 155-161. 被引量:1
  • 9Caliskan M, Erdogan D, Gullu H, et al. Effects of atrovastatin on coronary flow reserve in patients with slow coronary flow. Clin Cardiol, 2007, 30: 475479. 被引量:1
  • 10Cakmak M, Tanriverdi H, Cakmak N, et al. Simvastatin may improve myocardial perfusion abnormality in slow coronary flow. Cardiology, 2008, 110: 39-44. 被引量:1

共引文献22

同被引文献39

  • 1陈懿,徐世鄂.瑞舒伐他汀和阿托伐他汀对冠心病患者的调脂作用和安全性比较[J].中国老年学杂志,2014,34(9):2389-2390. 被引量:93
  • 2Tambe AA,Demany MA,Zimmerman HA,et al. Angina pectorisand slow flow velocity of dye in coronary arteries-a newangiographic finding[J]. Am Heart J,1972,84(1):66-71. doi:10.1016/0002-8703(72)90307-9. 被引量:1
  • 3Nie SP,Wang X,Geng LL,et al. Anatomic properties of coronaryarteries are correlated to the corrected thrombolysis in myocardialinfarction frame count in the coronary slow flow phenomenon[J].Coron Artery Dis,2012,23(3):174- 180. doi:10.1097/mca.0b013e328351554f. 被引量:1
  • 4Sezgin AT,Sigirci A,Barutcu I,et al. Vascular endothelial functionin patients with slow coronary flow[J]. Arq Bras Cardiol,2003,14(2):155-161. doi:10.1097/00019501-200304000-00008. 被引量:1
  • 5Gibson CM,Cannon CP,Daley WL,et al. TIMI frame count aquantitative method of assessing coronary artery flow [J].Circulation,1996,93(5):879-888. doi:10.1161/01.CIR.93.5.879. 被引量:1
  • 6Lin ZP,Dong M,Liu J. Bisoprolol improved endothelial functionand myocardiumsurvival of hypertension with stable angina:arandomized double-blinded trial[J]. Eur Rev Med Pharmacol Sci,2013,17(6):794-801. 被引量:1
  • 7Billinger M,Seiler C,Fleisch M,et al. Do beta- adrenergicblocking agents increase coronary flow reserve-[J]. J Am CollCardiol,2001,38(7):1866-1871. doi:10.1016/s0735-1097(01)01664-3. 被引量:1
  • 8Kaumann AJ,Lemoine H. Direct labelling of myocardial beta1-adrenoceptors comparison of binding affinity of 3H-(-)-bisoprololwith its blocking potency[J]. Naunyn- Schmiedebergs Archivespharmacol,1985,331(1):27-39. doi:10.1007/bf00498849. 被引量:1
  • 9Egashira K,Katsuda Y,Mohri M,et al. Role of endotheliumderivednitric oxide in coronary vasodilatation induced by pacingtachycardia in humans[J]. Circ Res,1996,79(2):331-335. doi:10.1016/S1062-1458(97)83255-2. 被引量:1
  • 10Toda N,Toda H. Coronary hemodynamic regulation by nitric oxidein experimental animals:recent advances[J]. Eur J Pharmacol,2011,667(1/2/3):41-49. doi:10.1016/j.ejphar.2011.06.028. 被引量:1

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部